w.QUIZ_APP_DATA.questions["BIO103-ENZ12"] = [
  // Questions 1-27: Enzymes
  {
    question: "1. All the following statements are true with regard to enzymes except:",
    answers: {
      a: "Enzymes lower activation energy.",
      b: "They alter equilibrium of the reaction.",
      c: "They accelerate the chemical reaction.",
      d: "Most of the enzymes are proteins in nature"
    },
    correctAnswer: "b",
    explanation: "Enzymes accelerate reactions by lowering activation energy but do not alter the equilibrium of the reaction [cite: 8, 163]."
  },
  {
    question: "2. In competitive inhibition:",
    answers: {
      a: "Inhibitor has structural similarity to substrate.",
      b: "Kₘ is decreased.",
      c: "Vmax is decreased.",
      d: "Reaction rate is independent of substrate concentration."
    },
    correctAnswer: "a",
    explanation: "The competitive inhibitor structurally resembles the substrate and competes for the enzyme's active site [cite: 12, 172]."
  },
  {
    question: "3. In competitive enzyme activity inhibition",
    answers: {
      a: "The structure of inhibitor is similar to that of the substrate",
      b: "Inhibitor decreases apparent Km",
      c: "Km remains unaffected",
      d: "Inhibitor decreases Vmax without affecting Km"
    },
    correctAnswer: "a",
    explanation: "The competitive inhibitor must have a structure similar to the substrate to bind to the active site [cite: 17]."
  },
  {
    question: "4. The optimum pH of most of the enzymes is",
    answers: {
      a: "Between 2 and 4",
      b: "Between 5 and 9",
      c: "Between 8 and 12",
      d: "Above 12"
    },
    correctAnswer: "b",
    explanation: "Most physiological enzymes have an optimal pH in the range between 5 and 9 [cite: 23, 178]."
  },
  {
    question: "5. Enzymes, which are produced in inactive form in the living cells, are called",
    answers: {
      a: "Papain",
      b: "Lysozymes",
      c: "Apoenzymes",
      d: "Proenzymes"
    },
    correctAnswer: "d",
    explanation: "Proenzymes (or Zymogens) are inactive precursors that are activated when needed [cite: 30, 187]."
  },
  {
    question: "6. The isoenzymes LDH5 is elevated in",
    answers: {
      a: "Myocardial infarction",
      b: "Peptic ulcer",
      c: "Liver disease",
      d: "Infectious diseases"
    },
    correctAnswer: "c",
    explanation: "LDH5 is primarily found in the liver and skeletal muscle, so its elevation is characteristic of Liver disease [cite: 34]."
  },
  {
    question: "7. Activation or inactivation of certain enzymes is accomplished by covalent modification of the amino acid:",
    answers: {
      a: "Hydroxy lysine",
      b: "Phenylalanine",
      c: "Lysine",
      d: "Serine"
    },
    correctAnswer: "d",
    explanation: "Covalent modification, usually phosphorylation/dephosphorylation, commonly occurs on the hydroxyl group of Serine [cite: 41, 193]."
  },
  {
    question: "8. These enzymes have different structure but the same catalytic function. Frequently they are oligomers made from different polypeptide chains. These enzymes are called:",
    answers: {
      a: "Allosteric enzymes",
      b: "Isozymes",
      c: "Proenzymes",
      d: "Zymogens"
    },
    correctAnswer: "b",
    explanation: "Isozymes are different structural forms of an enzyme that catalyze the same reaction [cite: 47, 197]."
  },
  {
    question: "9. In competitive enzyme activity inhibition, the inhibitor",
    answers: {
      a: "Increases Vmax",
      b: "Decreases Vmax",
      c: "Does not affect Vmax",
      d: "Decreases Vmax and Km"
    },
    correctAnswer: "c",
    explanation: "Competitive inhibition can be completely overcome by increasing substrate concentration, thus Vmax is not affected [cite: 53, 199]."
  },
  {
    question: "10. What type of enzyme inhibitor would have the following effects: Vmax unchanged Km increased Higher [S] needed to reach Vmax/2",
    answers: {
      a: "Competitive reversible inhibition",
      b: "Allosteric inhibition",
      c: "Irreversible inhibition",
      d: "All of the above"
    },
    correctAnswer: "a",
    explanation: "The pattern of Vmax unchanged and Km increased is the kinetic signature of Competitive reversible inhibition [cite: 55, 56]."
  },
  {
    question: "11. Which of these enzymes is increased in myocardial infarction?",
    answers: {
      a: "Alkaline phosphatase",
      b: "Glutamate-oxaloacetate transaminase",
      c: "Acid Phosphatase",
      d: "Creatine Kinase (CK-MB)"
    },
    correctAnswer: "d",
    explanation: "Creatine Kinase (CK-MB) is the specific isoenzyme for cardiac (heart muscle) damage, elevated in myocardial infarction [cite: 65, 202]."
  },
  {
    question: "12. As regards isoenzymes, which of the following is incorrect:",
    answers: {
      a: "They have similar polypeptide chains.",
      b: "They have different affinity to the substrate",
      c: "They can be separated by electrophoresis.",
      d: "They catalyze the same reaction"
    },
    correctAnswer: "a",
    explanation: "Isoenzymes are distinguished by having different polypeptide chains (subunits) in varying combinations. Statement A is incorrect [cite: 67, 206]."
  },
  {
    question: "13. Which statement is incorrect regarding feedback inhibition:",
    answers: {
      a: "Inhibition is usually allosteric.",
      b: "The final end product inhibits an enzyme catalyzing an early step of the metabolic pathway.",
      c: "It prevents the accumulation of unnecessary excessive products.",
      d: "It is a type of competitive inhibition."
    },
    correctAnswer: "d",
    explanation: "Feedback inhibition is typically a form of allosteric (non-competitive) inhibition, not competitive inhibition [cite: 75, 210]."
  },
  {
    question: "14. Allosteric inhibition of an enzyme involves which of the following?",
    answers: {
      a: "Binding of an inhibitor to a site other than the substrate binding site.",
      b: "Binding of an inhibitor competitively to the substrate binding site.",
      c: "Binding of an inhibitor noncompetitively to the substrate binding site.",
      d: "Allosteric inhibitors increase the affinity of the enzyme to its substrate."
    },
    correctAnswer: "a",
    explanation: "Allosteric regulation involves the effector binding to a regulatory site that is separate from the substrate binding site [cite: 77, 216]."
  },
  {
    question: "15. Enzymes accelerate reactions by _____ the activation energy needed for the reaction.",
    answers: {
      a: "stopping",
      b: "raising",
      c: "lowering",
      d: "binding"
    },
    correctAnswer: "c",
    explanation: "Enzymes function as catalysts by lowering the activation energy (ΔG‡) of a reaction [cite: 86]."
  },
  {
    question: "16. In competitive inhibition, the inhibitor:",
    answers: {
      a: "Competes with the enzyme.",
      b: "Irreversibly binds with the enzyme.",
      c: "Binds with the substrate.",
      d: "Competes with the substrate."
    },
    correctAnswer: "d",
    explanation: "A competitive inhibitor competes with the substrate for the same active (catalytic) site [cite: 92]."
  },
  {
    question: "17. The allosteric inhibitor of an enzyme:",
    answers: {
      a: "Causes the enzyme to work faster",
      b: "Binds to the active site",
      c: "Participates in feedback regulation",
      d: "Denatures the enzyme"
    },
    correctAnswer: "c",
    explanation: "Allosteric inhibitors are often involved in metabolic control, such as feedback regulation [cite: 96]."
  },
  {
    question: "18. When the velocity of enzyme activity is plotted against substrate concentration, which of the following is obtained?",
    answers: {
      a: "Hyperbolic curve",
      b: "Parabola",
      c: "Straight line with positive slope",
      d: "Straight line with negative slope"
    },
    correctAnswer: "a",
    explanation: "The plot of reaction velocity against substrate concentration for Michaelis-Menten enzymes yields a Hyperbolic curve [cite: 101]."
  },
  {
    question: "19. The drug allopurinol is prescribed to inhibit which of the following enzymes?",
    answers: {
      a: "Adenosine deaminase",
      b: "AMP deaminase",
      c: "Nucleoside phosphorylase",
      d: "Xanthine oxidase"
    },
    correctAnswer: "d",
    explanation: "Allopurinol is a suicide inhibitor that blocks Xanthine oxidase to reduce uric acid production and treat gout [cite: 112]."
  },
  {
    question: "20. In enzyme kinetics Km is:",
    answers: {
      a: "The substrate concentration that gives one half Vmax",
      b: "The dissociation constant for the enzyme substrate complex",
      c: "Concentration of enzyme",
      d: "Half of the substrate concentration required to achieve Vmax"
    },
    correctAnswer: "a",
    explanation: "Km (Michaelis constant) is defined as the substrate concentration that produces half of the maximal velocity (Vmax/2) [cite: 114]."
  },
  {
    question: "21. Non steroidal anti inflammatory drugs, such as aspirin act by inhibiting the activity of the enzyme:",
    answers: {
      a: "Lipoxygenase",
      b: "Cyclooxygenase",
      c: "Phospholipase A2",
      d: "Lipoprotein lipase"
    },
    correctAnswer: "b",
    explanation: "Non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin inhibit the enzyme Cyclooxygenase (COX) [cite: 122]."
  },
  {
    question: "22. Regulation of some enzymes by covalent modification involves addition or removal of",
    answers: {
      a: "Acetate",
      b: "Sulphate",
      c: "Phosphate",
      d: "Coenzyme"
    },
    correctAnswer: "c",
    explanation: "The most common covalent modification for enzyme regulation is phosphorylation/dephosphorylation, involving a Phosphate group [cite: 128]."
  },
  {
    question: "23. An inorganic ion required for the activity of an enzyme is known as",
    answers: {
      a: "Activator",
      b: "Cofactor",
      c: "Coenzyme",
      d: "None of the above"
    },
    correctAnswer: "b",
    explanation: "An inorganic ion (like Mg²⁺ or Zn²⁺) required for enzyme activity is called a metal ion Cofactor [cite: 132]."
  },
  {
    question: "24. The isozyme CK-MB is specifically increased in the blood of patients who had",
    answers: {
      a: "Skeletal muscle disease",
      b: "Recent myocardial infarction",
      c: "Infective hepatitis",
      d: "Brain infarction"
    },
    correctAnswer: "b",
    explanation: "CK-MB is the specific isoenzyme for heart muscle damage, indicating a Recent myocardial infarction [cite: 137]."
  },
  {
    question: "25. Multiple forms of the same enzymes are known as",
    answers: {
      a: "Zymogens",
      b: "Pre-enzymes",
      c: "Proenzymes",
      d: "Isoenzymes"
    },
    correctAnswer: "d",
    explanation: "Isoenzymes are different molecular forms (often with different subunits) of the same enzyme [cite: 144]."
  },
  {
    question: "26. An allosteric enzyme influences the enzyme activity by",
    answers: {
      a: "Competing for the catalytic site with the substrate",
      b: "Changing the specificity of the enzyme for the substrate",
      c: "Changing the conformation of the enzyme by binding to a site other than catalytic site",
      d: "Changing the nature of the products formed"
    },
    correctAnswer: "c",
    explanation: "Allosteric regulation involves binding to a non-catalytic site, which changes the enzyme's conformation and alters its activity [cite: 148]."
  },
  {
    question: "27. An enzyme is a",
    answers: {
      a: "Carbohydrate",
      b: "Lipid",
      c: "Protein",
      d: "Nucleic acid"
    },
    correctAnswer: "c",
    explanation: "The majority of enzymes are catalysts composed of Protein [cite: 153]."
  },
  {
    question: "28. All the following statements are true with regard to enzymes except:",
    answers: {
      a: "Enzymes lower activation energy.",
      b: "They alter equilibrium of the reaction.",
      c: "They accelerate the chemical reaction.",
      d: "Most of the enzymes are proteins in nature."
    },
    correctAnswer: "b",
    explanation: "Enzymes lower activation energy and accelerate reactions, but they do not change the equilibrium position of the reaction."
  },
  {
    question: "29. In competitive inhibition:",
    answers: {
      a: "Inhibitor has structural similarity to substrate.",
      b: "Km is decreased.",
      c: "Vmax is decreased.",
      d: "Reaction rate is independent of substrate concentration."
    },
    correctAnswer: "a",
    explanation: "A competitive inhibitor resembles the substrate structurally and competes for binding at the enzyme’s active site."
  },
  {
    question: "30. The optimum pH of most of the enzymes is:",
    answers: {
      a: "Between 2 and 4",
      b: "Between 5 and 9",
      c: "Between 8 and 12",
      d: "Above 12"
    },
    correctAnswer: "b",
    explanation: "Most enzymes function best at a pH close to physiological values, usually between 5 and 9."
  },
  {
    question: "31. Enzymes, which are produced in inactive form in the living cells, are called:",
    answers: {
      a: "Papain",
      b: "Lysozymes",
      c: "Apoenzymes",
      d: "Proenzymes"
    },
    correctAnswer: "d",
    explanation: "Proenzymes (also called zymogens) are inactive enzyme precursors that require activation to become functional."
  },
  {
    question: "32. Activation or inactivation of certain enzymes is accomplished by covalent modification of the amino acid:",
    answers: {
      a: "Hydroxy lysine",
      b: "Phenylalanine",
      c: "Lysine",
      d: "Serine"
    },
    correctAnswer: "d",
    explanation: "Covalent modification often involves phosphorylation or dephosphorylation of serine residues to regulate enzyme activity."
  },
  {
    question: "33. These enzymes have different structure but the same catalytic function. Frequently they are oligomers made from different polypeptide chains. These enzymes are called:",
    answers: {
      a: "Allosteric enzymes",
      b: "Isozymes",
      c: "Proenzymes",
      d: "Zymogens"
    },
    correctAnswer: "b",
    explanation: "Isozymes are distinct molecular forms of the same enzyme that catalyze the same reaction but differ in structure or kinetics."
  },
  {
    question: "34. In competitive enzyme activity inhibition, the inhibitor:",
    answers: {
      a: "Increases Vmax",
      b: "Decreases Vmax",
      c: "Does not affect Vmax",
      d: "Decreases Vmax and Km"
    },
    correctAnswer: "c",
    explanation: "Competitive inhibitors increase Km (require more substrate) but do not affect Vmax since inhibition can be overcome at high substrate concentrations."
  },
  {
    question: "35. Which of these enzymes is increased in myocardial infarction?",
    answers: {
      a: "Alkaline phosphatase",
      b: "Glutamate-oxaloacetate transaminase",
      c: "Acid phosphatase",
      d: "Creatine kinase (CK-MB)"
    },
    correctAnswer: "d",
    explanation: "Creatine kinase MB isoenzyme (CK-MB) is specific to cardiac muscle and rises in blood after myocardial infarction."
  },
  {
    question: "36. As regards isoenzymes, which of the following is incorrect:",
    answers: {
      a: "They have similar polypeptide chains.",
      b: "They have different affinity to the substrate.",
      c: "They can be separated by electrophoresis.",
      d: "They catalyze the same reaction."
    },
    correctAnswer: "a",
    explanation: "Isoenzymes differ in their polypeptide composition, so it is incorrect to say they have similar chains."
  },
  {
    question: "37. Which statement is incorrect regarding feedback inhibition:",
    answers: {
      a: "Inhibition is usually allosteric.",
      b: "The final end product inhibits an enzyme catalyzing an early step of the metabolic pathway.",
      c: "It prevents the accumulation of unnecessary excessive products.",
      d: "It is a type of competitive inhibition."
    },
    correctAnswer: "d",
    explanation: "Feedback inhibition typically involves allosteric inhibition, not competitive inhibition, and helps regulate metabolic pathways."
  },
  {
    question: "38. Allosteric inhibition of an enzyme involves which of the following?",
    answers: {
      a: "Binding of an inhibitor to a site other than the substrate binding site.",
      b: "Binding of an inhibitor competitively to the substrate binding site.",
      c: "Binding of an inhibitor noncompetitively to the substrate binding site.",
      d: "Allosteric inhibitors increase the affinity of the enzyme to its substrate."
    },
    correctAnswer: "a",
    explanation: "Allosteric inhibitors bind to a separate regulatory site, causing conformational changes that reduce enzyme activity."
  }
];

